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Increasing evidence indicates that the Hoxa11 
gene plays a critical role in the proper development 
of the uterus. In this report, we describe potential 
altered cellular processes in the developing uterus 
of Hoxa11 mutants. Histologic analysis demon­
strates normal uterine morphology in Hoxa11 mu­
tants as compared with controls at the newborn 
stage and d 7 after birth. Stromal tissue was mod­
erately reduced in the Hoxa11 mutant uterus by d 
14 after birth and was absent by d 21 after birth. 
There is decreased cellular proliferation in the 
Hoxa11 mutant uterus both at 7 and 14 d after birth. 
Terminal deoxyribonucleotide transferase-medi­
ated deoxyuridine triphosphate nick-end labeling
Medical Institute, University o f Utah School o f
analysis demonstrates that apoptosis was mark­
edly increased in the Hoxa11 mutant uterus at d 14 
after birth. p27 is decreased in the Hoxa11 mutant 
as evidenced by real-time PCR. Epidermal growth 
factor receptor expression is dramatically de­
creased as evidenced by both real-time PCR and 
immunohistochemistry results. These findings 
suggest that Hoxa11 is required for proper cellular 
proliferation and apoptotic responses in the devel­
oping neonatal uterus and that the regulation of 
epidermal growth factor receptor is critical to 
these processes. (Molecular Endocrinology 18: 
184-193, 2004)
K  IORMAL UTERINE GROWTH in mice occurs dur- 
I N  ing the neonatal stages after birth. From the day 
of birth to d 3, the uterine lumen becomes complex in 
shape surrounded by several layers of mesenchymal 
cells (1). The mesenchyme segregates into distinct 
stromal and myometrial layers by 5 d after birth (1). By 
d 10, the luminal epithelium becomes more complex in 
shape and uterine glands extend from the luminal ep­
ithelium into the stroma. The basic adult configuration 
of the uterus is established by d 15 with complex 
luminal epithelial folding and a random orientation of 
the endometrial stromal nuclei (1).
Although the morphologic and histologic appear­
ance of the murine uterus throughout development 
has been well established, the profile of genes that is 
critical to uterine proliferation and differentiation dur­
ing the neonatal time period is unknown. Expression 
studies have revealed several factors present in the 
developing uterus including epidermal growth factor 
(EGF), EGF receptor (EGFR), keratinocyte growth fac­
tor (KGF), KGF receptor, and estrogen receptors (2-6). 
The importance of these genes in the proper develop­
ment of the female reproductive tract, however, has
Abbreviations: BrdU, Bromodeoxyuridine; cdk, cyclin- 
dependent kinase; EGF, epidermal growth factor; EGFR, EGF 
receptor; G3PDH, glyceraldehyde-3-phosphate dehydroge­
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not been established. Furthermore, estrogen recep­
tors are prime examples of protein being present in 
uterine stroma throughout neonatal development (5­
7), but not affecting uterine proliferation as evidenced 
by ovariectomy/adrenalectomy studies (8). This non­
reliance of neonatal uterine growth upon estrogen is 
further evidenced by the normally developed repro­
ductive tissues of both the aERKO (estrogen receptor 
a null) and /3ERKO (estrogen receptor /3 null) mice (9).
Gene targeting studies have identified several genes 
with possible roles in uterine development. However, 
the exact role that some of these genes (Pax-2, Emx-2, 
Wnt-4) play in the growth and differentiation of the 
uterus cannot be ascertained due to the complete 
absence of the uterus in the mutant animals (10-12). 
Similarly, the exact role of Sp4, a transcription factor, 
in uterine differentiation and proliferation has not been 
established. Despite the findings of a reduced uterine 
size in the adult Sp4 knockout animal, neonatal uterine 
tissue was not examined (13).
In contrast, abnormal adult uterine morphology re­
sulting from targeted gene disruptions has implicated 
the potential role of homeobox-containing genes in the 
development of the female reproductive tract. One of 
these homeobox genes, Hoxa11, is part of a family of 
genes that provides cells with specific positional iden­
tities, which result in the proper development and spa­
tial arrangement of organs and structures along the 
anterior-posterior axis (14,15). This genetic regulation 
consists of a set of structurally similar genes that were 
originally discovered in Drosophila through homeotic 
transformations (16). These genes possess a se­
quence of 180 bp (the homeobox) encoding a 60-
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amino acid DNA-binding motif (the homeodomain). In 
turn, the homeodomains are part of larger proteins that 
function as sequence-specific transcription factors 
(17). Currently, it is believed that the Hox genes, acting 
individually or in concert with each other, coordinate a 
multitude of downstream target genes that assemble 
functioning, region-specific tissue and organs (15, 
18-21).
Hoxa11 homozygous mutant adult females mice are 
sterile, producing no offspring when mated with their 
wild-type counterparts (22). The female Hoxa11 defi­
cient mice produced a defective uterine environment 
with high embryo absorption rates in the homozy­
gotes. Further investigations into the role of Hoxa11 
gene in the differentiation and function of the female 
reproductive tract have revealed abnormal stromal 
and glandular cell development in adult mutant uteri 
(23). These same Hoxa11 adult female mutants also 
failed to display a normal decidual reaction secondary 
to natural or artificial stimuli (23). Taken together, 
Hoxa11 may be critical for normal uterine stromal cell 
and glandular differentiation and implantation.
Further evidence of the importance of Hoxa11 in the 
developing reproductive tract is suggested by the lo­
calization of Hoxa11 transcripts in the immature stro­
mal cells of the Mullerian ducts of E14 embryos (22). 
Hoxa11 continues to be expressed in the stromal cells 
of the developing female reproductive tract and is 
also expressed in the uterine epithelial cells by 2 wk of 
age (24).
Despite the growing evidence of Hox gene involve­
ment in the female reproductive tract, the exact role of 
Hoxa11 in uterine development is not known. More 
specifically, what cellular mechanisms and genes are 
altered in Hoxa11 mutants in the proper development 
of the murine uterus have not been established.
In this report, we investigate the role of Hoxa11 gene 
in the development of the female reproductive tract. At 
the histologic level, the Hoxa11 mutant uterus was 
observed to be identical to the wild-type uterus at the 
newborn stage and 7 d after birth. The amount of 
stromal tissue was moderately decreased in the 
Hoxa11 mutant uterus by d 14 after birth and was 
absent by d 21 after birth. Bromodeoxyuridine (BrdU) 
cellular proliferation studies demonstrated decreased 
cellular proliferation in the Hoxa11 mutant uterus both 
at 7 and 14 d after birth. Terminal deoxyribonucleotide 
transferase-mediated deoxyuridine triphosphate nick- 
end labeling (TUNEL) analysis demonstrated that ap- 
optosis was markedly increased in the Hoxa11 mutant 
uterus at d 14 after birth. The expression of many 
genes involved in cell cycle regulation and apoptosis 
at both 7 and 14 d after birth was normal except for a 
marked decrease in p27. EGFR expression is dramat­
ically decreased as evidenced by both real-time quan­
titative RT-PCR (QRT-PCR) and immunohistochemis- 
try results. These findings suggest that Hoxa11 is 
involved in controlling cellular proliferation and apo- 
ptotic responses in the neonatal uterus and that the 
regulation of EGFR is critical to these processes.
RESULTS 
Abnormal Adult and Neonatal Uterine 
Morphology in Homozygous Hoxa11 Mutant Mice
The generation of the Hoxa11 mutant has been previ­
ously described (15, 25). Examination of uteri obtained 
from adult Hoxa11 mutants shows a reduction in size 
compared with wild-type adults. The uterine diameter 
is dramatically smaller as well as the overall uterine 
length (not shown). Histologically, Hoxa11 adult mu­
tant uteri displayed little to no stromal tissue (labeled
S) as well as no endometrial glands (arrows) compared 
with wild-type controls (Fig. 1). The luminal epithelium 
(labeled E) and the surrounding muscular layers (la­
beled M) appear to be normal, histologically.
The abnormal histologic appearance of the uterus in 
Hoxa11 mutant adults, especially the minimal amount 
of stromal tissue, does not originate from the lack of 
stroma in early developmental stages. Examination 
during neonatal time points has revealed the uteri from 
Hoxa11 mutants as having normal appearing stromal 
tissue in the newborn stage (Fig. 2, A and B) and d 7 
after birth (Fig. 2, C and D) as compared with wild-type 
controls. However, the amount of stromal tissue ap­
pears to decrease as development progresses (Fig. 2, 
E-H). Stromal tissue is decreased in the mutant in 
comparison to wild-type control mice by d 14 after 
birth (Fig. 2, E and F). By 21 d after birth, the mutant 
uteri display a histologic architecture similar to an 
adult mutant configuration of minimal to no stromal 
tissue and absent endometrial glands (Fig. 2, G and H).
Decreased Neonatal Uterine Cellular Proliferation 
and Increased Apoptosis in Homozygous Hoxa11 
Mutant Mice
To determine the basis of the abnormal stromal tissue, 
we examined cellular proliferation and apoptosis in the 
uteri of Hoxa11 mutants. Based upon our findings of 
little to no stromal tissue remaining in the d 21 Hoxa11 
mutants, we concentrated our investigations on d 7 
and 14 after birth time points. Cellular proliferation, as 
evidenced by BrdU incorporation, was altered in both 
the stromal and the epithelial components of the mu­
tants (Fig. 3). Hoxa11 mutants exhibited decreased 
BrdU incorporation in the uterine stroma at both 7 
(3.43 vs. 6.38% in wild-type, Fig. 3C) and 14 d (4.24 vs. 
10.95%, Fig. 3E) of age. In contrast, the epithelial 
components of Hoxa11 mutants exhibited decreased 
proliferation only at d 7 after birth (11.73 vs. 16.62%, 
Fig. 3D). BrdU incorporation at d 7 after birth in the 
Hoxa11 mutants was similar to wild-type controls 
(10.58 vs. 9.02%, Fig. 3F).
In addition to decreased cellular proliferation, 
Hoxa11 mutants also exhibited increased apoptosis in 
the uterus. TUNEL analysis was performed on uteri 
obtained from both wild-type and Hoxa11 mutants at 
d 7 and 14 after birth. At d 7, both wild-type and 
Hoxa11 mutant mice exhibited minimal to no apopto-
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Fig, 1, Representative Hematoxoylin and Eosin Uterine Sections (X100) from Wild-Type (WT) (A) and H o xa ll Mutant ( - / - )  (B) 
Adult Mice (>8 wk)
The stromal tissue (S) and endometrial glands (black arrows) in the wild-type uterine section are absent in the Hoxa11 mutant. 
The endometrial luminal lining (E) and outer muscular layers (M) appear to be similar in the wild-type and mutant uteri.
N e w b o r n  7  d a y  1 4  d a y  2 1  d a y
Fig, 2, Uterine Sections (A and B, X400, C-H, X250) Stained with Hematoxylin and Eosin from Wild-Type (WT) and H o xa ll 
Mutant ( - / - )  Mice at Newborn, 7, 14, and 21 d after Birth 
The amount of stromal tissue (s) between the luminal epithelium (e) and the muscular layers and the number of endometrial 
glands in the wild-type uterine section is similar to the Hoxa11 mutant at the newborn stage (A and B) and d 7 of life (C and D). 
By d 14 (E and F), there is diminished stromal tissue in the Hoxa11 mutant compared with control. There is an absence of uterine 
stromal tissue by 21 d after birth in the Hoxal 1 mutant (G and H). In addition, there are minimal to absent endometrial glands in 
the Hoxal 1 mutant at 21 d after birth.
sis in the uterus (Fig. 4, A and B). By d 14, there is 
markedly increased apoptosis in the mutant uterus as 
evidenced by greatly increased fluorescence as com­
pared with control (Fig. 4, C and D). The apoptosis as 
evidenced by TUNEL appears throughout the uterus 
including the stromal area.
Altered Neonatal Uterine Gene Expression in 
Hoxa11 Mutants
To characterize the alteration in neonatal uterine gene 
expression between wild-type and Hoxal 1 mutants,
we used QRT-PCR analysis on cDNA samples gener­
ated from uterine extracted RNA. Based on the BrdU 
and TUNEL data, examination was focused upon 
genes important in cellular proliferation and apoptosis. 
Important regulators of the cell cycle and proliferation 
include the cyclin proteins. These proteins regulate the 
passage through the various phases of the cell cycle 
including cyclin D1 and E in the G1 phase, cyclin A in 
the S phase, and cyclin B in the G2 phase (26). Reg­
ulators of apoptosis include BAX as a promoter of 
apoptosis and Bcl-2 as a suppressor of apoptosis (27).
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Fig. 3. BrdU Incorporation
A and B, Representative histologic sections of BrdU incorporation (X400). BrdU incorporation (white arrows) in representative 
wild-type (WT) (A) and mutant ( - / - )  (B) uteri at 14 d after birth. C-F, BrdU incorporation represented by mean percentage of 
BrdU-positive cells/total number of cells per high power field 4 se (n = 4 animals). Stromal BrdU incorporation is significantly (*, 
P < 0.05) decreased in mutant tissues compared with wild-type both at 7 and 14 d of life (C and E). Epithelial BrdU incorporation 
is decreased significantly (*, P <  0.05) in d 7 mutant mice compared with wild-type (D). Epithelial BrdU incorporation is not 
significantly different in 14 d neonatal mutants as compared with controls (F).
Examination of the expression of several genes im­
plicated in uterine development was also performed. 
Both EGF and EGFR have been implicated to play a 
role in the developing female reproductive tract by 
expression data (2) and EGFR-KO grafting data (28). 
Growth factors such as EGF and its receptor, EGFR, 
play critical roles in cellular proliferation and apoptosis 
(29). Alterations in the expression of either uterine EGF 
or EGFR in the Hoxa11 mutant could result in the 
abnormal stromal development found in the adults.
Gene targeting studies have identified several genes 
that may have roles in the developing reproductive 
tract. Wnt7a is a member of a family of genes pattern­
ing and cell-to-cell communication. Targeted removal 
of Wnt7a leads to abnormal female reproductive de­
velopment and results in diminished stromal tissue 
and a reduced number of endometrial glands in the 
adult (30). Another Hox family member, Hoxa 10, has 
also been implicated in proper reproductive tract de­
velopment. In contrast to Hoxa11 mutants, Hoxa10
mutants only display abnormal uterine morphology in 
the proximal horn of the uterus (31).
The QRT-PCR data are reported as the fold change 
between wild-type and Hoxa11 mutants. Because we 
were looking for major differences in expression, 
which may have more biologic significance, we de­
fined a change as greater than 2-fold difference. By 
QRT-PCR, there was no difference in mRNA levels of 
genes implicated in cell proliferation or apoptosis in­
cluding cyclin A, cyclin B1, cyclin D1, cyclin E, BAX, or 
Bcl-2 transcripts between wild-type and mutant ani­
mals at 7 d after birth (Table 1). In addition, the ex­
pression of genes implicated in uterine development, 
Wnt7a, Hoxa10, EGF, and EGFR, did not reveal any 
difference in transcript levels (Table 1).
In contrast, Hoxa10 and cyclin E transcript levels 
were 3.5- and 3.4-fold decreased in Hoxa11 mutants 
at d 14 after birth (Table 1). At 14 d of age, EGFR 
expression was decreased by 12.8-fold in Hoxa7 7 mu­
tants. There was no difference in uterine levels of
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Fig. 4. TUNEL Analysis
Representative fluorescent images of TUNEL staining in uterine histologic sections from wild-type (WT) and Hoxa11 mutant 
( - / - )  mice at 7 and 14 d after birth. There is minimal apoptosis (red fluorescence) in both wild-type (A) and mutant (B) uteri at 
7 d after birth. By d 14, there remains minimal apoptosis in the wild-type uterus (C). In contrast, the mutant d 14 uterus displays 
increased apoptosis in the stromal areas as evidenced by intense fluorescent signaling (D).
cydin A, cyclin B1, cyclin D1, BAX, Bcl-2, Wnt7a, and 
EGF between mutant and wild-type mice at 14 d after 
birth (Table 1).
Genes implicated in the regulation of EGFR, Sp1 
and p53, were also examined at 7 and 14 d of age. The 
transcription factor, Sp1, and the tumor suppressor, 
p53, have both been implicated in the regulation of 
EGFR (32, 33). The expression of Sp1 and p53 were 
found to be no different between wild-type and 
Hoxa11 mutants both at 7 and 14 d of age (Table 1).
Altered Cell Cycle Mediator Gene in 
Hoxa11 Mutants
Based on the BrdU data, further examination was fo­
cused upon genes important in the cell cycle. By QRT- 
PCR, there was no difference in mRNA levels of genes 
implicated in the cell cycle including p15, p18, p21, 
p57, cdk2, cdk4, and cdk6 between wild-type and 
mutant animals at 14 d afterbirth (Table 2). In contrast, 
pRB (retinoblastoma) transcript levels were slightly de­
creased by 2.07-fold and p27 transcript levels were 
markedly decreased by 7.1-fold in Hoxa11 mutant
uteri. These data, taken together with decreased 
EGFR expression, suggest that Hoxa11 regulates 
genes essential for normal cellular proliferation in the 
developing female reproductive tract.
Decreased EGFR Uterine Stromal Expression in 
Hoxa11 Mutants
To further validate the finding of markedly decreased 
uterine expression of EGFR transcripts in the Hoxa11 
mutant, changes in the expression pattern of EGFR 
were examined by immunohistochemistry. The ex­
pression of EGFR protein in the uterine stroma at 7 d 
after birth was similar between the Hoxa11 mutant and 
wild-type, which correlated with the finding of similar 
amounts of transcripts by QRT-PCR (not shown). At d
14 after birth, however, the expression of EGFR 
(brown staining) in the uterine stroma (labeled s) was 
greatly reduced in the Hoxa11 mutant compared with 
wild-type (Fig. 5). In addition, expression of EGFR was 
reduced in the epithelial component (labeled e) of the 
mutant (Fig. 5).
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Cyclin A -0 .2 -0.4
Cyclin B1 1.2 0
Cyclin D1 1.9 -0.9
Cyclin E -0 .9 -3.4
Apoptosis
Bax -1 .2 1.7
Bcl-2 -0 .8 -1.3
Implicated in uterine development
Hoxal 0 1.8 -3.5
Wnt7a -1.1 -0.9
EGF -1 .5 -1.4
EGFR -0 .7 -12.8
EGFR regulation
SP1 -1 .4 -1.5
p53 -0 .8 -0.9
Negative numbers represent decreased expression in the 
mutant. Positive numbers represent increased expression in 
the mutant.
Table 2. Expression of Cell 
Knockout Mouse at 14 d











Negative numbers represent decreased expression in the 
mutant. Positive numbers represent increased expression in 
the mutant.
DISCUSSION
The present study provides new insights into Hoxal 1 
regulation of normal uterine development. In particu­
lar, Hoxal 1 is critical to the normal nonsteroid asso­
ciated uterine growth in the neonate. Utilizing the 
Hoxal 1 mutant, we present evidence of several mech­
anisms/pathways that may be involved in the proper 
formation of normal uterine morphology in the adult 
mouse. In addition, we demonstrate evidence of al­
tered expression of a previously implicated gene in 
uterine development, EGFR, in Hoxal 1 mutants.
Interestingly, uteri from Hoxal 1 mutants appear his­
tologically normal in early neonatal stages and develop 
abnormalities as the animals increase in age. The find­
ings of no discernible morphologic differences in uteri 
between Hoxal 1 mutants and wild-type controls both
at the newborn stage and d 7 after birth would suggest 
that Hoxa11 is not critical in establishing the Mullerian 
duct. Instead, our findings would indicate that Hoxal 1 
is necessary for the continued growth of the reproduc­
tive tract during the neonatal time period. The normal 
expression of Hoxal 1 appears to be critical for stromal 
tissue development but not for epithelial or muscular 
development in the uterus. Despite the normal mor­
phologic appearance of the epithelial and muscular 
components, however, the functionality of these tis­
sues may be altered in the mutants. This is supported 
by the findings of a normal histologic appearance of 
three fourths of the uterus in HoxalO mutants but the 
inability to support implantation of wild-type embryos 
in this normal appearing area of the uterus (31).
The uterine hypoplasia seen in the Hoxal 1 mutants 
is caused by a combination of increased stromal cell 
death with decreased stromal cell proliferation. Sev­
eral investigators have previously found alterations in 
proliferation or cell death in other Hox mutants. Tar­
geted null mutations in Hox genes in combination with 
transcription factors have been associated with both 
elevated apoptosis and decreased cell proliferation in 
the thymus of Hoxa3+/~Pax~/~mutants (34). In addi­
tion, elevated apoptosis with unaffected cellular pro­
liferation has been detected in the hindbrains of Hoxal 
mutants and HoxalHoxbl double mutants (21, 35). 
Differential proliferation has also been proposed as a 
mechanism for Hox regulation of limb patterning and 
skeletal formation (25, 36). Thus, our data appear to 
implicate Hoxal 1 in promoting proper proliferation 
and survival of stromal cells in the developing uterus.
We were unable to detect any major alterations 
(greater than 2-fold difference) in the expression of the 
majority of cell cycle regulators or apoptotic genes 
except for a marked decrease in p27, a small decrease 
in cyclin E and pRB. Cyclins, cyclin-dependent ki­
nases (cdk), and cdk inhibitors are the major regulators 
of the cell cycle and are implicated in multiple cellular 
processes including cell proliferation and differentia­
tion (26). Cdk inhibitor p27 is an antiproliferative me­
diator of the cell cycle and the p27 knockout animals 
have displayed organomegaly and cellular hyperplasia 
(37). Some investigators, however, have found p27 to 
be an activator of cdks (38), which is implicated by our 
findings of decreased p27 in the Hoxal 1 mutants. Our 
results of altered expression of several cell cycle reg­
ulating genes may contribute to the abnormal cellular 
proliferation displayed in the Hoxal 1 mutants.
Similar to cell proliferation and cell cycle regulation, 
apoptosis is a cellular process involving many path­
ways and numerous factors (39). Our choice of inves­
tigating only BAX and Bcl-2, two members of the Bcl-2 
family, may again have limited our study. Expanding 
our investigation to include other apoptotic proteins 
may further enhance our understanding of how 
Hoxal 1 regulates cell proliferation and apoptosis.
Hoxal 1 does not appear to regulate Wnt7a in the 
developing uterus. Previous investigators have found 
that Wnt7a expression is necessary to maintain the
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Fig. 5. EGFR Expression in the 14-d Uterus of Wild-Type (WT) and H oxa l1 Mutant ( - / - )  Mice 
A, In the WT animal, EGFR is expressed (brown staining) throughout the stromal (s) and epithelial (e) components. (B) There 
is minimal EGFR staining in both the stroma and luminal epithelia in the Hoxal 1 mutant. Magnification, X400.
expression of Hoxal 1 in the uterus (30). Wnt7a mu­
tants eventually lose the expression of Hoxal 1 and 
Hoxal0 in the stroma of the adult uterus. Our finding of 
possible unaltered Wnt7a expression in the neonatal 
uteri of Hoxal 1 mutants is consistent with the hypoth­
esis that Hoxa11 is downstream of Wnt7a in the de­
veloping reproductive tract.
Although our findings show that Hoxal 1 does not 
appear to regulate HoxalO in the developing uterus, 
the possibility still exists that other Hox genes may be 
altered in the developing uterus of Hoxal 1 mutants. 
Other Hox genes besides HoxalO and Hoxa11 have 
been reported to be expressed in the uterus (24, 40, 
41). In addition, the Hoxa13 null mutant displays agen­
esis of the caudal portion of the Mullerian ducts (42). 
Hox genes have also been demonstrated to regulate 
the expression of other Hox genes. Hoxal is required 
to establish the expression of Hoxbl in the hindbrain 
(35) and the expression of Hoxb2 in rhombomere 4 of 
the hindbrain appears to be regulated by Hoxbl (43). 
Therefore, determining whether other Hox genes may 
be altered in the uterus of the Hoxal 1 mutant should 
provide further insights in the Hoxal 1 regulation of the 
reproductive tract.
The uterine defects in Hoxal 1 mutants may be, in 
part, mediated through EGFR. EGF and EGFR have 
both been implicated in uterine development, espe­
cially as mediators of estrogen action. The role of 
EGFR in the steroid-independent time period of neo­
natal uterine growth, however, is less well established. 
While the expression of both EGF and EGFR has been 
reported in the uterus of neonatal mice, no functional 
data exist (2, 3). Our findings of decreased EGFR 
transcript and protein in the stroma of Hoxal 1 mutants 
point, for the first time, to the potential importance of 
EGFR in the proper development of the uterus in neo­
natal mice. Although the findings of unaltered expres­
sion of Sp1 and p53, both regulators of EGFR tran­
scription, help point to the possibility of the direct 
regulation of EGFR by Hoxal 1, the establishment of 
EGFR as a true transcriptional target of Hoxal 1 would 
require further studies.
The examination of the uterus in EGFR knockout 
animals would further substantiate the importance of 
EGFR in the developing uterus. The EGFR knockout 
animal, however, survives up to only 8 d after birth (44). 
Our data seem to indicate that EGFR expression is 
normal in Hoxal 1 mutants at d 7 after birth. Examina­
tion of EGFR knockout animals at older ages (d 14) 
would require a conditional knockout of EGFR.
In summary, we have demonstrated that the abnor­
mal uterine morphology of Hoxal 1 mutants arises dur­
ing neonatal development and results from a combi­
nation of decreased cellular proliferation as well as 
increased cell death. The uterine expression of cell 
cycle regulators is altered in Hoxa11 mutants. We have 
also shown that EGFR expression is severely dimin­
ished in the stromal tissue of the neonatal mutants. 
Taken together, these findings suggest that Hoxal 1 
directly or indirectly regulates cellular proliferating 
genes and, in turn, controls cellular growth and apo- 
ptotic responses in the developing neonatal uterus.
MATERIALS AND METHODS
Animals and Genotyping
Hoxal 1 null mutant mice were generated by homologous 
recombination with embryonic stem cells as previously de­
scribed (15, 25). All experimental procedures involving ani­
mals were performed in accordance with the University of 
Utah Animal Care Committee guidelines.
PCR assays, performed on genomic DNA, were used for 
genotyping to distinguish between wild-type and mutant al­





Uterine tissues were obtained from wild-type and Hoxal 1 
mutant mice (C57BL/6 background) at newborn, 7, 14, and
21 d after birth. Tissues were fixed in 4% vol/vol paraformal­
dehyde and then embedded in paraffin. Tissue sections (5
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/xm) were deparaffinized and rehydrated for histologic, im- 
munohistochemical and immunofluorescent analyses. For 
light microscopic examination, tissue sections were stained 
with hematoxylin and eosin.
BrdU Incorporation
For the assessment of cell proliferation, neonatal wild-type 
and Hoxa11 mutant mice were killed 2 h after BrdU (30 /xg/g 
of body weight, Sigma Diagnostics, St. Louis, MO) was ad­
ministered ip. Uterine sections obtained from BrdU-treated 
mice were fixed with 4% vol/vol paraformaldehyde and then 
embedded in paraffin. Tissue sections (5 /xm) were deparaf­
finized, rehydrated and labeled with the 5-Bromo-2'-Deoxy- 
Uridine Labeling and Detection Kit II (Roche Molecular Bio­
chemicals, Indianapolis, IN). The percentage of BrdU positive 
cells/1000 cells counted by three independent blinded eval­
uators was averaged. Statistical analysis was performed with 
the ANOVA statistical testing by using the SAS statistical 
package (SAS Institute, Cary, NC). Statistical significance 
was defined as P < 0.05.
TUNEL Labeling
Apoptosis was detected by using TUNEL analysis with the In 
Situ Death Detection Kit (Roche Molecular Biochemicals) on 
deparaffinized uterine sections. Samples were analyzed with 
confocal fluorescence microscopy.
Real-time RT-PCR
After genotyping, uteri were obtained from wild-type and 
Hoxa11 mutant mice at 7 and 14 d after birth. Six animals with 
identical genotypes in the 7-d-old groups (wild-type and 
Hoxa11 mutant), and four animals with identical genotypes in 
the 14-d-old group were pooled together to obtain sufficient 
total RNA for each sample. Total RNA was extracted with 
TRIzol (Invitrogen, Carlsbad, CA). One microgram of deoxyri­
bonuclease l-treated RNA was reverse transcribed with 
Moloney murine leukemia virus reverse transcriptase (Invitro­
gen, Inc.) to generate cDNA.
Gene-specific primers corresponding to the investigated 
genes were used for the QRT-PCR. The primer pairs used 
are listed in Table 3. QRT-PCR was performed with the Light- 
Cycler-based SYBR Green I detection system (Roche Mo­
lecular Biochemicals). Dilutions of cDNA were amplified at a 
specified annealing temperature determined by the specific 
primer pair. Amplification was followed by a melting curve 
analysis. Negative controls without cDNA were used to as­
sess specificity. A stable housekeeping gene, glyceralde- 
hyde-3-phosphate dehydrogenase (G3PDH) was used to 
control for input RNA. The amount of transcript was deter­
mined based on the fluorescence i/s. cycle number plot. The 
cycle crossing point for each gene was determined by the 
LightCycler Software version 3.39 program (Roche Molecular 
Biochemicals). After adjusting with the G3PDH control, the 
difference in cycle crossing points were calculated for each 
gene between the wild-type group and mutants for a specific 
time point. For a theoretical efficiency of 100%, the fold 
difference was calculated by 2 to the power of the cycle point 
difference.
Immunohistochemistry
To compare the expression of EGFR in Hoxa11 mutant uteri 
i/s. wild-type uteri, fixed deparaffinized uterine sections were 
first treated with 2% hydrogen peroxide in methanol to 
quench endogenous peroxide activity. The uterine sections 
were then incubated with 3% normal goat serum to block 
endogenous nonspecific Ig binding sites. Sections were then 
incubated with anti-EGFR rabbit antibody (Santa Cruz Bio­
technologies, Santa Cruz, CA) at a predetermined dilution of 
1:200 in blocking solution overnight at 4 C. After incubation 
with primary antibody, the sections were washed and immu- 
noreactivity was assessed with the antirabbit goat biotinyl- 
ated secondary antibody followed by avidin-biotin horse rad­
ish peroxidase complex (Santa Cruz Biotechnologies) and 
visualized with diaminobenzidene tetrahydrochloride (Santa 
Cruz Biotechnologies). Slides were counterstained with 
methyl green, then rinsed and mounted with Cytoseal (Ste­
phens Scientific, Riverdale, NJ). Omission of primary anti­
body was used as a negative control.
Table 3. Primer Sequences for QRT-PCR
Gene Forward Sequence Reverse Sequence
G3PDH 5'-TGAAGGTCGGTGTGAACGGATTTGGC 5'-CATGTAGGCCATGAGGTCCACCAC
Cyclin A 5 '-T CCAAGAGGACCAGGAGAATAT CA 5' -TCCT CATGGTAGT CT G GTACTT C A
Cyclin B1 5' -CC ATTATT G ATCGGTT CAT GCAG A 5'-CTAGTGGAGAATTCAGCTGTGGTA
Cyclin D1 5 '-T GGAGCCCCT GAAGAAGAG 5'-AAGTGCGTTGTGCGGTAGC
Cyclin E 5'-CTGGCTGAATGTTTATGTCC 5'-TCTTTGCTTGGGCTTTGTCC
BAX 5 '-CT GAGCT GACCTT GGAGC 5 '-GACT CCAGCCACAAAGAT G
Bcl-2 5 '-GACAGAAGAT CAT GCCGT CC 5'-GGTACCAATGGCACTTCAAG
Wnt7a 5'-GACAAATACAACGAGGCCGT 5'-GGCTGTCTTATTGCAGGCTC
Hoxa10 5 '-GCTGTCT CCAAGCCCCTTCAGA 5'-AAAGTTGGCTGTGAGCTCCCG
EGF 5' -AGAT GAGTGTGTGCTG GCTAGAT C 5' -TCCG AGTCCTGTAGTAGTAAGTCC
EGFR 5'-GTGTGAAGAAGTGCCCCCGAAAC 5 '-AACGACCGCCAAAGAAAACT GACC
Sp1 5'-AGATGTTGGTGGCAATAATGGG 5 '-TGAAAGTT GT GTGGCT GT GAGG
p53 5'-TGAAACGCCGACCTATCCTTA 5 '-GGCACAAACACGAACCT CAAA
p15 5' -CACCGT GAC ATT GCG AG GTATC 5'-TGGGTAGGGTTCAAG I I I IGGAAG
p18 5'-CCAATGGGCTCAC I I I IGCTG 5 '-CCTTT CCTTT GCT CCTAAT CAGG
P21 5'-GGATTCCCTGGTCTTACCTTAGGC 5' - AG AAGTCACT G AG AACCCC AACT G
p27 5 '-AGCCT GGAGCGGAT GGACGC 5'-CACCTTGCAGGCGCTCTTGG
p57 5'-GCCGGGTGATGAGCTGGGAA 5 '-AGAGAGGCTGGT CCTT CAGC
Cdk2 5' -ATT CAT G G ATGCCTCTGCTCT CAC 5 '-GGT CAAT CT CAGAAT CT CCAGGGAA
Cdk4 5 '-AT CAGCACAGTT CGT GAGGT GGC 5'-AGCTCGGTACCAGACTGTAAC AAC
Cdk6 5' -T GCACAGT GT CACGAACAGAC 5'-TGAATGAAAAGCCTGCCTGGG
pRB 5 '-GAACAGATTT GT CCTT CCCGT G 5'-TCAGGTCCTTCTCCATCCTTGG
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